Literature DB >> 13678858

Migration of Toxoplasma gondii across biological barriers.

Antonio Barragan1, L David Sibley.   

Abstract

The molecular mechanisms underlying migration of pathogens across biological barriers remain poorly characterized. Following oral infection, the apicomplexan parasite Toxoplasma gondii actively crosses non-permissive biological barriers such as the intestine, the blood-brain barrier and the placenta, thereby gaining access to tissues where it causes severe pathology. Recently, enhanced migration was found to be associated with virulent strains of Toxoplasma, suggesting that this phenotype contributes to pathogenesis. The migratory machinery appears to be morphologically and functionally well conserved within the phylum of apicomplexan parasites, however, the mechanisms for cellular traffic to breach biological barriers remain to be elucidated. As penetration of host tissue is a prerequisite for the establishment of infections by most apicomplexan parasites, understanding parasite migration is crucial for the development of new approaches to combat disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13678858     DOI: 10.1016/s0966-842x(03)00205-1

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  63 in total

1.  Tissue barriers of the human placenta to infection with Toxoplasma gondii.

Authors:  Jennifer R Robbins; Varvara B Zeldovich; Anna Poukchanski; John C Boothroyd; Anna I Bakardjiev
Journal:  Infect Immun       Date:  2011-11-14       Impact factor: 3.441

2.  Structural basis for chirality and directional motility of Plasmodium sporozoites.

Authors:  Mikhail Kudryashev; Sylvia Münter; Leandro Lemgruber; Georgina Montagna; Henning Stahlberg; Kai Matuschewski; Markus Meissner; Marek Cyrklaff; Friedrich Frischknecht
Journal:  Cell Microbiol       Date:  2012-07-30       Impact factor: 3.715

3.  Gliding motility leads to active cellular invasion by Cryptosporidium parvum sporozoites.

Authors:  Dawn M Wetzel; Joann Schmidt; Mark S Kuhlenschmidt; J P Dubey; L David Sibley
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

4.  Characterization of metalloproteases and serine proteases of Toxoplasma gondii tachyzoites and their effect on epithelial cells.

Authors:  Carlos J Ramírez-Flores; Rosalba Cruz-Mirón; Rossana Arroyo; Mónica E Mondragón-Castelán; Tais Nopal-Guerrero; Sirenia González-Pozos; Emmanuel Ríos-Castro; Ricardo Mondragón-Flores
Journal:  Parasitol Res       Date:  2018-12-01       Impact factor: 2.289

5.  Unusual kinetic and structural properties control rapid assembly and turnover of actin in the parasite Toxoplasma gondii.

Authors:  Nivedita Sahoo; Wandy Beatty; John Heuser; David Sept; L David Sibley
Journal:  Mol Biol Cell       Date:  2005-11-30       Impact factor: 4.138

6.  Evaluation of various methods of maternal placental blood collection for immunology studies.

Authors:  Caroline Othoro; Julie M Moore; Kathleen Wannemuehler; Bernard L Nahlen; Juliana Otieno; Laurence Slutsker; Altaf A Lal; Ya Ping Shi
Journal:  Clin Vaccine Immunol       Date:  2006-05

Review 7.  Subversion of innate and adaptive immune responses by Toxoplasma gondii.

Authors:  Christine Lang; Uwe Gross; Carsten G K Lüder
Journal:  Parasitol Res       Date:  2006-10-06       Impact factor: 2.289

Review 8.  Forward genetics in Toxoplasma gondii reveals a family of rhoptry kinases that mediates pathogenesis.

Authors:  L David Sibley; Wei Qiu; Sarah Fentress; Sonya J Taylor; Asis Khan; Raymond Hui
Journal:  Eukaryot Cell       Date:  2009-05-22

9.  When should a trophically and vertically transmitted parasite manipulate its intermediate host? The case of Toxoplasma gondii.

Authors:  Maud Lélu; Michel Langlais; Marie-Lazarine Poulle; Emmanuelle Gilot-Fromont; Sylvain Gandon
Journal:  Proc Biol Sci       Date:  2013-07-03       Impact factor: 5.349

Review 10.  Concepts and mechanisms: crossing host barriers.

Authors:  Kelly S Doran; Anirban Banerjee; Olivier Disson; Marc Lecuit
Journal:  Cold Spring Harb Perspect Med       Date:  2013-07-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.